WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke AMESOPAX wurde als Wortmarke am 07.12.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1718653 |
| Registernummer | 302022010071 |
| Länder | 
|
| Basismarke |
Nr. 30 2022 010 071,
20. Juli 2022
|
| Anmeldedatum | 07. Dezember 2022 |
| Ablaufdatum | 07. Dezember 2032 |
Markeninhaber
Im Neuenheimerfeld 517
69120 Heidelberg
DE
69120 Heidelberg
DE
Markenvertreter
Schreiberstr. 20
79098 Freiburg
DE
Waren und Dienstleistungen
01
Stem cells for scientific use; stem cells for research use;
cell growth media for growing cells for scientific use; stem
cells for aesthetic purposes
05
Drugs for medical purposes; pharmaceutical and veterinary
preparations; diagnostic agents; pharmaceutical
preparations; preparations for medical purposes;
preparations for biomedical purposes; pharmaceutical cell
preparations for medical use; substances for medical use;
substances for biomedical purposes; live implants for
pharmaceutical purposes; biochemical and chemical products
for medical use; biochemical and chemical products for
pharmaceutical purposes; biochemical and chemical products
for diagnostic purposes; proteins for medical purposes;
biological preparations for medical and veterinary purposes,
and pharmaceutical and veterinary preparations, all for
external and systemic use; biological, pharmaceutical and
veterinary preparations for skin care for medical purposes;
medical dressings; preparations for wound treating and
healing; biological, pharmaceutical and veterinary
preparations for the treatment of chronic wounds, ulcers,
burns and surgical wounds; stem cells for medical purposes;
stem cells for veterinary purposes; somatic stem cell
therapeutics; fibroblasts for medical purposes; fibroblasts
for surgical beauty purposes; pharmaceutical implants;
surgical implants derived from stem cells; surgical implants
derived from fibroblasts; biological tissue for
implantation; growth media for culturing cells for medical
purposes; pharmaceutical preparations for tissue
regeneration; vascular grafts; living tissue;
biotechnologically engineered tissue products
42
Pharmaceutical drug development; scientific and
technological services; research and development services in
the fields of cell diagnostics and cell therapy and surgical
and medical instruments; industrial analysis and research
services; scientific research for medical purposes; stem
cell research; scientific and medical research and
development; scientific research, testing and analysis
services; medical research; biomedical research; research
and development in the field of biotechnology; research and
development in the field of gene therapy; research and
development in the field of immunology; research and
development in the field of antibodies; research and
development in the field of antibody technology; research
and development in the field of bacteriology; research and
development in the field of gene expression systems;
research and development in the field of vaccines;
development of industrial processes; industrial process
research; research and development services for the
pharmaceutical industry; research and development of new
products for others; consultancy in the field of
pharmaceutical research; providing information about medical
and scientific research for pharmaceutical products;
preparation of reports relating to scientific research
44
Medical services; medical diagnostic services [carrying out
tests and analyses]; medical assistance; clinic services;
hospital services; plastic and cosmetic surgery; medical
therapies; medical services relating to the removal,
treatment, processing and storage of human cells and tissue,
stem cells and bone marrow, also in the field of
regenerative medicine, including tissue engineering; medical
services in connection with the removal, treatment,
processing and storage of human tissue and stem cells, also
in the field of regenerative medicine, including tissue
engineering; medical services relating to the cultivation
and procurement of stem cells; medical services in
connection with the cultivation and procurement of stem
cells
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 07. Juni 2023 | 2023/23 Gaz | AU | Ablehnung |
| 07. Juni 2023 | 2023/23 Gaz | GB | Ablehnung |
| 18. Mai 2023 | 2023/20 Gaz | RU | Ablehnung |
| 12. Mai 2023 | 2023/19 Gaz | PH | Ablehnung |
| 29. März 2023 | 2023/14 Gaz | EM | Ablehnung |
| 07. Dezember 2022 | 2023/9 Gaz | DE | Eintragung |
ID: 141718653